Diclofenac Sodium And Misoprostol Tablet, Delayed Release
Product Images NDC 0591-0397

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium And Misoprostol (NDC 0591-0397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Drug facts text panel for Diclofenac Sodium and Misoprostol Delayed-Release Tablets, USP 50 mg/0.2 mg. The label provides active ingredient amounts, storage instructions, a boxed warning about pregnancy risks, dispensing guidance, manufacturer details (Teva Pharmaceuticals USA, Inc.), and a barcode with serialization information.*

FDA Label Image

Image 2

Label for Diclofenac Sodium and Misoprostol delayed-release tablets, USP, 75 mg/0.2 mg, in a pack of 60 tablets. The label includes dispensing instructions for pharmacists, storage conditions, a boxed warning about pregnancy risks, and manufacturer information for Teva Pharmaceuticals USA, Inc. The label also features a barcode and serialization coding area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.